Fulminant mulch pneumonitis: An emergency presentation of chronic granulomatous disease

Clinical Infectious Diseases

Volumn 45, Issue 6, 2007, Pages 673-681

  Siddiqui, Sophia ^a   Anderson, Victoria L ^a   Hilligoss, Diane M ^a   Abinun, Mario ^c   Kuijpers, Taco W ^d   Masur, Henry ^b   Witebsky, Frank G ^b   Shea, Yvonne R ^b   Gallin, John I ^a   Malech, Henry L ^a   Holland, Steven M ^a,e  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^d EMMA CHILDREN S HOSPITAL   (Netherlands)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; CEFTAZIDIME; CEFTRIAXONE; COTRIMOXAZOLE; FLUCLOXACILLIN; GAMMA INTERFERON; GENTAMICIN; IMIPENEM; ITRACONAZOLE; LEVOFLOXACIN; MEROPENEM; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; OXACILLIN; PREDNISONE; PROTEIN P47; PROTEIN P47 PHOX; RIFAMPICIN; UNCLASSIFIED DRUG; VORICONAZOLE;

ADOLESCENT; ADULT; AEROSOL; ARTICLE; ASPERGILLUS; BACTERIUM CULTURE; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DYSPNEA; EMERGENCY CARE; FEMALE; FEVER; GRANULOMATOSIS; HUMAN; HYPOXIA; IMMUNE DEFICIENCY; LUNG BIOPSY; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MORTALITY; MYCOSIS; PNEUMONIA; PRIORITY JOURNAL; RADIODIAGNOSIS; RECURRENT INFECTION; SCHOOL CHILD; STREPTOMYCES; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ASPERGILLUS; CHILD; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; FEMALE; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; LUNG DISEASES, FUNGAL; MALE; MIDDLE AGED; NADPH OXIDASE; PNEUMONIA;

EID: 34548508186     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520985     Document Type: Article

References (33)

1. Bridges RA, Berendes H, Good RA. A fatal granulomatous disease of childhood: the clinical, pathological, and laboratory features of a new syndrome. AMA J Dis Child 1959; 97:387-408.
2. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 2000; 79:170-200.
3. Segal BH, DeCarlo ES, Kwon-Chung KJ, Malech HL, Gallin JI, Holland SM. Aspergillus nidulans infection in chronic granulomatous disease. Medicine (Baltimore) 1998; 77:345-54.
4. Segal BH, Kuhns DB, Ding L, Gallin JI, Holland SM. Thioglycollate peritonitis in mice lacking C5, 5-lipoxygenase, or p47 (phox): complement, leukotrienes, and reactive oxidants in acute inflammation. J Leukoc Biol 2002; 71:410-6.
5. Marciano BE, Rosenzweig SD, Kleiner DE, et al. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics 2004; 114: 462-8.
6. Winkelstein JA, Marino MC, Johnston RB Jr, et al. Chronic granulomatous disease: report on a national registry of 368 patients. Medicine (Baltimore) 2000; 79:155-69.
7. Dorman SE, Guide SV, Conville PS, et al. Nocardia infection in chronic granulomatous disease. Clin Infect Dis 2002; 35:390-4.
8. Nerurkar LS, Jacob A, Zeligs B, Walser J, Yeager H Jr, Bellanti JA. Chronic granulomatous disease in an adult. South Med J 1987; 80: 1296-302.
9. Crosdale DJ, Poulton KV, Ollier WE, Thomson W, Denning DW. Mannose-binding lectin gene polymorphisms as a susceptibility factor for chronic necrotizing pulmonary aspergillosis. J Infect Dis 2001; 184: 653-6.
10. Almyroudis NG, Holland SM, Segal BH. Invasive aspergillosis in primary immunodeficiencies. Med Mycol 2005; 43:S247-59.
11. Marciano BE, Wesley R, De Carlo ES, et al. Long-term interferon-γ therapy for patients with chronic granulomatous disease. Clin Infect Dis 2004; 39:692-9.
12. Clancy CJ, Nguyen MH. Acute community-acquired pneumonia due to Aspergillus in presumably immunocompetent hosts: clues for recognition of a rare but fatal disease. Chest 1998; 114:629-34.
13. Parameswaran K, Joshi M, Ravindran P. Unusual radiological presentation and rapid fatal progression of invasive pulmonary aspergillosis in an immunocompetent young patient. Respirology 1999; 4:287-90.
14. Batard E, Renaudin K, Morin O, Desjars P, Germaud P. Fatal acute granulomatous pulmonary aspergillosis in a healthy subject after inhalation of vegetal dust. Eur J Clin Microbiol Infect Dis 2003; 22:357-9.
15. Marr KA, Patterson T, Denning D. Aspergillosis: pathogenesis, clinical manifestations, and therapy. Infect Dis Clin North Am 2002; 16:875-94, vi.
16. Pollock JD, Williams DA, Gifford MA, et al. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet 1995; 9:202-9.
17. Chang YC, Segal BH, Holland SM, Miller GF, Kwon-Chung KJ. Virulence of catalase-deficient aspergillus nidulans in p47 (phox)-/-mice: implications for fungal pathogenicity and host defense in chronic granulomatous disease. J Clin Invest 1998; 101:1843-50.
18. Schapiro BL, Newburger PE, Klempner MS, Dinauer MC. Chronic granulomatous disease presenting in a 69-year-old man. N Engl J Med 1991; 325:1786-90.
19. Greenberger PA. Allergic bronchopulmonary aspergillosis, allergic fungal sinusitis, and hypersensitivity pneumonitis. Clin Allergy Immunol 2002; 16:449-68.
20. Aksamit TR. Hot tub lung: infection, inflammation, or both? Semin Respir Infect 2003; 18:33-9.
21. Morgenstern DE, Gifford MA, Li LL, Doerschuk CM, Dinauer MC. Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus. J Exp Med 1997; 185:207-18.
22. Eppinger TM, Greenberger PA, White DA, Brown AE, Cunningham-Rundles C. Sensitization to Aspergillus species in the congenital neutrophil disorders chronic granulomatous disease and hyper-IgE syndrome. J Allergy Clin Immunol 1999; 104:1265-72.
23. Walsh T, Schaufele R, Sein T, et al. Reduced expression of galactomannan antigenemia in patients with invasive aspergillosis and chronic granulomatous disease or Job's syndrome [abstract 345]. In: Program and abstracts of the 40th annual meeting of the Infectious Diseases Society of America (Chicago). Alexandria, VA: Infectious Diseases Society of America, 2002:105.
24. Steinbach WJ, Stevens DA, Denning DW. Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001. Clin Infect Dis 2003; 37:S188-224.
25. Segal BH, Barnhart LA, Anderson VL, Walsh TJ, Malech HL, Holland SM. Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection. Clin Infect Dis 2005; 40:1684-8.
26. Okano M, Yamada M, Ohtsu M, et al. Successful treatment with methylprednisolone pulse therapy for a life-threatening pulmonary insufficiency in a patient with chronic granulomatous disease following pulmonary invasive aspergillosis and Burkholderia cepacia infection. Respiration 1999; 66:551-4.
27. Boogaerts M, Winston DJ, Bow EJ, et al; Itraconazole Neutropenia Study Group. Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy: a randomized, controlled trial. Ann Intern Med 2001; 135:412-22.
28. Herbrecht R, Denning DW, Patterson TF, et al.; Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347:408-15.
29. Walsh TJ, Pappas P, Winston DJ, et al.; National Institute of Allergy and Infectious Diseases Mycoses Study Group. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med 2002; 346:225-34.
30. Walsh TJ, Teppler H, Donowitz GR, et al. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med 2004; 351:1391-402.
31. Guler N, Yalcin I, Salman N, Ones U. Invasive pulmonary aspergillosis in chronic granulomatous disease: response to systemic prednisolone treatment and locally applied amphotericin B. Turk J Pediatr 1994; 36:341-5.
32. Narita M, Shibata M, Togashi T, Tomizawa K, Matsumoto S. Steroid therapy for bronchopneumonia in chronic granulomatous disease. Acta Paediatr Jpn 1991; 33:181-5.
33. Beatty PG, Ochs HD, Harlan JM, et al. Absence of monoclonal-antibody- defined protein complex in boy with abnormal leucocyte function. Lancet 1984; 1:535-7.